SCHEMBL5752822

SCHEMBL5752822

O=C(O)C(Cc1ccc(C(F)(F)F)cc1)C(O)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.47
PPARA Q07869 4/20 0.47
EEF2K O00418 1/20 0.46
FPR2 P25090 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
HDAC4 P56524 1/20 0.40
SRD5A2 P31213 1/20 0.40
CPA1 P15085 1/20 0.40
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
EPHX2 P34913 1/20 0.39
PTPN1 P18031 1/20 0.39
GRB2 P62993 1/20 0.39
FFAR1 O14842 1/20 0.39
PDPK1 O15530 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5752665 0.85 PDE2A (0.46) PPARGPPARAL3MBTL1SLC1A1SRD5A2
SCHEMBL5751679 0.84 PPARG (0.44) PPARGPPARAFPR2L3MBTL1SRD5A2
SCHEMBL5750437 0.83 PPARG (0.51) PPARGPPARAFPR2L3MBTL1SLC1A3
SCHEMBL5752544 0.80 PDE2A (0.41) PPARGPPARAEEF2KFPR2HDAC4
SCHEMBL5751624 0.78 PPARG (0.44) PPARGPPARAL3MBTL1SRD5A2EPHX2
SCHEMBL5749682 0.78 PPARG (0.44) PPARGPPARAL3MBTL1SRD5A2EPHX2
SCHEMBL5751870 0.78 AKR1C3 (0.47) PPARGPPARAL3MBTL1SRD5A2EPHX2
SCHEMBL5749024 0.77 OPRM1 (0.47) PPARGPPARAFPR2L3MBTL1SLC1A1
SCHEMBL5754309 0.76 PPARG (0.53) PPARGPPARASRD5A2EPHX2FFAR1
SCHEMBL5755431 0.76 FFAR2 (0.52) EEF2KFPR2POLBFFAR1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP PPARG 905/4885PPARA 708/4885EEF2K 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.